FilingReader Intelligence
Renhe Pharmacy revenue falls 16% despite cash flow surge
August 25, 2025 at 08:02 AM UTC•By FilingReader AI
Renhe Pharmacy reported a 16.46% decrease in operating revenue to 1.98bn yuan and a 13.87% drop in net profit to 290.4m yuan for the first half of 2025.
However, the company saw a substantial 86.14% increase in net cash flow from operating activities to 671.4m yuan, despite the revenue decline.
No dividends will be distributed to shareholders.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
Primary Source Document
Supplementary Source Documents
2025 semi-annual financial reportAugust 25, 2025 at 08:00 AM UTC
Summary table of semi-annual non-operating fund appropriation and other related party fund transactionsAugust 25, 2025 at 08:00 AM UTC
Special report on the deposit and use of raised funds for the first half of 2025August 25, 2025 at 08:00 AM UTC
2025 semi-annual report summaryAugust 25, 2025 at 08:00 AM UTC
Announcement of the board resolution on the semi-annual reportAugust 25, 2025 at 08:00 AM UTC
semi-annual report supervisory board resolution announcementAugust 25, 2025 at 08:00 AM UTC
SZSE:000650•Shenzhen Stock Exchange
News Alerts
Get instant email alerts when Renhe Pharmacy publishes news
Free account required • Unsubscribe anytime